Reading time: 4 minutes Ian Lock By directing immune cells to attack tumor cells, immunotherapy uses the body’s own biological mechanisms to target and eliminate cancer. Recently this concept has been retooled for another class of therapeutics that capitalizes on a cell’s internal processes to target cancer cells. Adapted from Promega PROTACs or proteolysis-targeted chimeric... Continue Reading →